intrathecal immunotherapySP26322C3NCI-H358PD-L1leptomeningeal metastasis
…with 22C3 and 61% (17/28) with SP263. For 24 patients receiving intrathecal immunotherapy, the correlation between PD-L1 expression and prognosis is bein…
1articles mentioning treatments
1treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: intrathecal immunotherapy ×
intrathecal immunotherapy
This treatment is selected. Its supporting articles are shown below.